Literature DB >> 17014335

In vitro fungistatic and fungicidal activities of silver sulfadiazine and natamycin on pathogenic fungi isolated from horses with keratomycosis.

Caroline M Betbeze1, Ching Ching Wu, Sheryl G Krohne, Jean Stiles.   

Abstract

OBJECTIVE: To evaluate the in vitro antifungal properties of silver sulfadiazine (SSD) and natamycin against filamentous fungi isolated from eyes of horses with keratomycosis. SAMPLE POPULATION: Filamentous fungal isolates obtained from eyes of keratomycosis-affected horses. PROCEDURES: Fungal culture of ocular samples yielded 6 Fusarium spp; 7 Aspergillus spp; and 1 isolate each of Curvularia, Scopulariopsis, Penicillium, and Chrysosporium. For each fungal isolate, minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) of SSD and natamycin were determined.
RESULTS: For all 17 fungal isolates, SSD MIC distribution ranged from < or = 1 to > 64 microg/mL; MIC50 and MIC90 (MICs at which 50% and 90% of organisms were inhibited) were 4 and 32 microg/mL, respectively. The SSD MFC distribution for all isolates was < or = 1 to > 64 microg/mL; MFC50 and MFC90 (MFCs at which 50% and 90% of organisms were killed) were 8 and > 64 microg/mL, respectively. For all fungal isolates, natamycin MIC distribution ranged from 256 to > 1,000 microg/mL; MIC50 and MIC90 were 512 and > 1,000 microg/mL, respectively. The natamycin MFC distribution for all isolates ranged from 512 to > 1,000 microg/mL; MFC(50) and MFC(90) were each > 1,000 microg/mL. CONCLUSIONS AND CLINICAL RELEVANCE: These in vitro data suggest that SSD is fungicidal against the fungal isolates that were obtained from eyes of horses with keratomycosis and that natamycin is fungicidal against some of the isolates at the drug concentrations evaluated. Silver sulfadiazine may be a therapeutic option for equine keratomycosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17014335     DOI: 10.2460/ajvr.67.10.1788

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  8 in total

1.  Diagnostic ophthalmology.

Authors:  Lynne S Sandmeyer; Bianca S Bauer; Kate Robinson; Bruce H Grahn
Journal:  Can Vet J       Date:  2014-03       Impact factor: 1.008

2.  Enhancement of antibacterial properties of Ag nanorods by electric field.

Authors:  Omid Akhavan; Elham Ghaderi
Journal:  Sci Technol Adv Mater       Date:  2009-01-19       Impact factor: 8.090

Review 3.  Optimal management of equine keratomycosis.

Authors:  Paula D Galera; Dennis E Brooks
Journal:  Vet Med (Auckl)       Date:  2012-03-12

Review 4.  Fungal keratitis: Mechanisms of infection and management strategies.

Authors:  Christopher Donovan; Eduardo Arenas; Ramesh S Ayyala; Curtis E Margo; Edgar M Espana
Journal:  Surv Ophthalmol       Date:  2021-08-20       Impact factor: 6.197

5.  Equine keratomycoses in California from 1987 to 2010 (47 cases).

Authors:  Z Reed; S M Thomasy; K L Good; D J Maggs; K G Magdesian; N Pusterla; S R Hollingsworth
Journal:  Equine Vet J       Date:  2012-09-04       Impact factor: 2.888

6.  Keratomycosis in captive red pandas (Ailurus fulgens): 2 cases.

Authors:  Hayley August Volk; Anu O'Reilly; Kate Bodley; Helen McCracken
Journal:  Open Vet J       Date:  2018-06-01

7.  Multi-locus DNA sequence analysis, antifungal agent susceptibility, and fungal keratitis outcome in horses from Southeastern United States.

Authors:  Megan Cullen; Megan E Jacob; Vicki Cornish; Ian Q VanderSchel; Henry Van T Cotter; Marc A Cubeta; Ignazio Carbone; Brian C Gilger
Journal:  PLoS One       Date:  2019-03-28       Impact factor: 3.240

8.  Case Report: Successful Management of Refractory Keratomycosis in an Alpaca Using Penetrating Keratoplasty and Combination Antifungal Therapy (Caspofungin 0.5% and Terbinafine 1%).

Authors:  Braidee C Foote; Joe S Smith; Anna Catherine Bowden; Rachel A Allbaugh; Lionel Sebbag
Journal:  Front Vet Sci       Date:  2021-03-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.